Panel Discussion: Uncovering Investor Priorities to Secure Cell Therapy Funding in 2027 & Beyond

9:00 am - Wednesday 10th February 2027

  • Exploring the differences between European and US investment environments to optimise fundraising strategies
  • Understanding the technologies, data packages and business models attracting investment to shape development strategies around evolving investor priorities
  • Identifying strategies to differentiate from growing competition and build compelling investment cases that attract capital
  • Discussing the future direction of the space to align with biotech innovation

Speakers:

Co-Founder & President
Alaya.Bio
Partner
Novo Ventures AS
Managing Director & Executive Partner
Abingworth